These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 22280379

  • 1. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC, Schober KE, Smith DN, Otoni CC, Li X, Bonagura JD.
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [Abstract] [Full Text] [Related]

  • 2. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
    Riesen SC, Schober KE, Cervenec RM, Bonagura JD.
    J Vet Intern Med; 2011 Apr 06; 25(3):469-76. PubMed ID: 21418320
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
    Blass KA, Schober KE, Li X, Scansen BA, Bonagura JD.
    J Vet Intern Med; 2014 Apr 06; 28(3):838-46. PubMed ID: 24597596
    [Abstract] [Full Text] [Related]

  • 5. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
    Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C.
    J Cardiovasc Pharmacol; 2012 Mar 06; 59(3):260-7. PubMed ID: 22075752
    [Abstract] [Full Text] [Related]

  • 6. [Left ventricular systolic and diastolic functions in hypertrophic cardiomyopathy: with special reference to clinical symptom and the effects of calcium blocking agent (nifedipine)].
    Yamakado T, Higashiyama S, Nakano T, Takezawa H.
    J Cardiol Suppl; 1987 Mar 06; 16():53-63. PubMed ID: 3509683
    [Abstract] [Full Text] [Related]

  • 7. Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.
    Sugimoto K, Aoki T, Fujii Y.
    J Vet Med Sci; 2020 May 15; 82(5):546-552. PubMed ID: 32188801
    [Abstract] [Full Text] [Related]

  • 8. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y, Mert U, Nadir A, Mutlu F, Morrad B, Ulus T.
    J Cardiovasc Med (Hagerstown); 2015 Sep 15; 16(9):603-9. PubMed ID: 24922198
    [Abstract] [Full Text] [Related]

  • 9. [Pathophysiology of hypertrophic and congestive cardiomyopathies: a guide of fundamental therapeutic approach (author's transl)].
    Hirota Y, Shimizu G, Kaku K, Furubayashi K, Kawamura K, Takatsu T.
    J Cardiogr; 1981 Dec 15; 11(4):1127-46. PubMed ID: 7201493
    [Abstract] [Full Text] [Related]

  • 10. Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats.
    Schober KE, Fuentes VL, Bonagura JD.
    Am J Vet Res; 2003 Jan 15; 64(1):93-103. PubMed ID: 12518885
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
    Becher PM, Lindner D, Miteva K, Savvatis K, Zietsch C, Schmack B, Van Linthout S, Westermann D, Schultheiss HP, Tschöpe C.
    Hypertension; 2012 May 15; 59(5):949-57. PubMed ID: 22493071
    [Abstract] [Full Text] [Related]

  • 13. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 15; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 14. Temporal effects of an infusion of dobutamine hydrochloride in horses anesthetized with halothane.
    Young LE, Blissitt KJ, Clutton RE, Molony V.
    Am J Vet Res; 1998 Aug 15; 59(8):1027-32. PubMed ID: 9706208
    [Abstract] [Full Text] [Related]

  • 15. Dobutamine stress echocardiography in hypertrophic cardiomyopathy.
    Losi MA, Betocchi S, Aversa M, Lombardi R, Miranda M, Cacace A, Ciampi Q, Tocchetti CG, Guida A, Chiariello M.
    Cardiology; 2003 Aug 15; 100(2):93-100. PubMed ID: 14557696
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M, Mackiewicz U.
    Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678
    [Abstract] [Full Text] [Related]

  • 19. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP, Naesheim T, Torgersen Engstad E, Kildal AB, Myrmel T, How OJ.
    Acta Physiol (Oxf); 2016 Oct 01; 218(2):78-88. PubMed ID: 27145482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.